Sensitive SPE-HPLC method to determine a novel angiotensin-AT1 antagonist in biological samples

Journal of Pharmaceutical and Biomedical Analysis

Volumn 35, Issue 2, 2004, Pages 321-329

  Rizzo, M ^a   Ventrice, D ^a   Monforte, F ^a   Procopio, S ^a   De Sarro, G ^b   Anzini, M ^c   Cappelli, A ^c   Makovec, F ^d  

^a University of Catanzaro Magna Graecia   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Rotta Research Laboratorium   (Italy)

Author keywords

Angiotensin AT1 antagonist; Pharmacokinetic; SPE HPLC

Indexed keywords

4 [4 [(2 ETHYL 5,7 DIMETHYLIMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL]PHENYL] 3 (2H TETRAZOL 5 YL)QUINOLINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CR 3210; LOXIGLUMIDE; SOLVENT; SORBENT; UNCLASSIFIED DRUG;

ACCURACY; ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; BIOLOGY; CALIBRATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG URINE LEVEL; ELUTION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION; MATERIALS; NONHUMAN; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SAMPLE; SOLID PHASE EXTRACTION; TIME; ULTRAVIOLET RADIATION; URINALYSIS; VALIDATION PROCESS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PROGLUMIDE; PURINES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; SENSITIVITY AND SPECIFICITY;

EID: 1942439720     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2003.12.004     Document Type: Conference Paper

References (15)

1. Ferrario C.M., Flack J.M. J. Cardiovasc. Drug Ther. 10:1996;511-518.
2. Tsikouris J.P., Cox C.D. Pharmacotherapy. 23:2003;1141-1152.
3. Stanton A. J. Renin Angiotensin Aldosterone Syst. 4:2003;6-10.
4. Wyvratt M.J., Patchett A.A. Med. Res. Rev. 5:1985;483-531.
5. Coulter M.D., Edwards I.R. Br. Med. J. 294:1987;1521-1523.
6. Erdos E.G., Skidgel R.A. Hypertension. 8:1986;1.
7. Quadri L., Gobbini M., Monti L. Curr. Pharm. Des. 4:1998;489-512.
8. De Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. Pharmacol. Rev. 52:2000;415-472.
9. Unger T. J. Hypertens. Suppl. 21:2003;3-7.
10. A. Cappelli, G. Pericot Mohr, A. Gallelli, M. Rizzo, M. Anzini, S. Vomero, L. Mennuni, F. Ferrari, F. Makovec, M.C. Menziani, P.G. De Benedetti, G. Giorgi, J. Med. Chem., submitted for publication.
11. Williams R.C., Alasandro M.S., Fasone V.L.et al. J. Pharm. Biomed. Anal. 14:1996;1539-1546.
12. Yeung P.K., Jamieson A., Smith G.J., Fice D., Pollak P.T. Int. J. Pharm. 204:2000;17-22.
13. Carlucci G., Palumbo G., Mazzeo P., Quaglia M.G. J. Pharm. Biomed. Anal. 23:2000;185-189.
14. Gonzales L., Lopez J.A., Alonzo R.M., Jimenez R.M. J. Chromatogr. A. 949:2002;49-60.
15. Rizzo M., Anzini M., Cappelli A., Vomero S., Ventrice D., De Sarro G., Procopio S., Costa N., Makovec F. Farmaco. 58:2003;837-844.